The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience
Robert A. Mitchell(Lake Erie College of Osteopathic Medicine), Brian Bressler(University of British Columbia)
Cited by 20
Related Papers
Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells
|Gastroenterology|2019|103
Isotretinoin and Risk for Inflammatory Bowel Disease
|JAMA Dermatology|2013|93